A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Omega Healthcare Investors's Debt-to-EBITDA or its related term are showing as below:
BSP:O2HI34'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.65 Med: 5.56 Max: 7.45
Current: 3.67
During the past 13 years, the highest Debt-to-EBITDA Ratio of Omega Healthcare Investors was 7.45. The lowest was 3.65. And the median was 5.56.
BSP:O2HI34's Debt-to-EBITDA is ranked better than 79.66% of 585
companies
in the REITs industry
Industry Median: 6.5
vs BSP:O2HI34: 3.67
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Omega Healthcare Investors Debt-to-EBITDA Related Terms
Omega Healthcare Investors Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:O2HI34 vs DOC, AHR, CTRE: Debt-to-EBITDA Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors Debt-to-EBITDA vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Omega Healthcare Investors (BSP:O2HI34) has a Debt-to-EBITDA of 3.78 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Omega Healthcare Investors. This is 32% below median its historical median of 5.56. Over the past decade, Omega Healthcare Investors' Debt-to-EBITDA has ranged from 3.65 to 7.45. According to the industry distribution chart, Omega Healthcare Investors ranks #119 out of 585 companies in the REITs industry, placing it in the top 20.3%.
Is Omega Healthcare Investors' Debt-to-EBITDA too high?
Omega Healthcare Investors' current Debt-to-EBITDA of 3.78 is 32% below median its 10-year median of 5.56. Over the past 10 years, this metric has ranged from a low of 3.65 to a high of 7.45. The REITs industry median Debt-to-EBITDA is 6.50. Omega Healthcare Investors' value of 3.78 is 41.8% below this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #119 out of 585 companies in the REITs industry, which is in the top quartile — a strong position relative to peers. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Debt-to-EBITDA compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #119 out of 585 companies for Debt-to-EBITDA. This places Omega Healthcare Investors in the top 20% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 6.50. Omega Healthcare Investors' value of 3.78 is 41.8% below this benchmark. Historically, Omega Healthcare Investors' own Debt-to-EBITDA has ranged from 3.65 to 7.45 over the past decade. While the company's 10-year median is 5.56 vs. the industry median of 6.50, Omega Healthcare Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a REITs company?
The median Debt-to-EBITDA among REITs companies is 6.50, based on 585 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current Debt-to-EBITDA of 3.78 is 41.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Omega Healthcare Investors. For the REITs industry, the median Debt-to-EBITDA is 6.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current Debt-to-EBITDA is 3.78, which is 32% below median its own 10-year median of 5.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current Debt-to-EBITDA is 3.78, which is 32% below median its 10-year median of 5.56 and 41.8% below the REITs industry median of 6.50. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Debt-to-EBITDA is 3.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
Debt-to-EBITDA: 3.78 (32% below median its 10-year median of 5.56)
GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
Industry Position: 41.8% below the REITs median (#119 of 585)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score
Get the complete analysis for BSP:O2HI34
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 
